EU approves Wyeth's improved hemophilia B drug

08/21/2007 |

The European Union approved a new version of Wyeth's hemophilia B drug BeneFix. The improved product contains a lower diluent volume for all dosage strengths, comes in a prefilled syringe, has a bigger IU vial and features a needle-less reconstitution device. Wyeth hopes these changes will make the treatment easier for patients to prepare and use.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT